|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and orphan diseases. Pharmace... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and orphan diseases Pharmaceu... |
|
|
Invention
|
Insulin receptor modulation for tumor associated hyperinsulinism. The present disclosure describe... |
|
2024
|
Invention
|
Alkylated inhibitors of plasma kallikrein. The present disclosure provides compounds of Formula (... |
|
|
Invention
|
High concentration formulations for anti-insulin receptor antibody and uses thereof. The present ... |
|
2023
|
Invention
|
Solid dosage forms of a plasma kallikrein inhibitor.
Described herein are high loading, stable s... |
|
|
Invention
|
Solid dosage forms of a plasma kallikrein inhibitor. Described herein are high loading, stable so... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of metabolic
diseases and orphan indications. Phar... |
|
|
Invention
|
Inhibitors of plasma kallikrein. The present disclosure provides compounds of Formula (IA) and th... |
|
|
Invention
|
Formulations for anti-insulin receptor antibody and uses thereof.
The present disclosure relates... |
|
|
Invention
|
Formulations for anti-insulin receptor antibody and uses thereof. The present disclosure relates,... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of hyperinsulinism; pharmaceutical p... |
|
2022
|
Invention
|
Processes for preparing plasma kallikrein inhibitors.
A process for preparing and purifying a co... |
|
|
Invention
|
Crystalline forms of plasma kallikrein inhibitors. Pure crystalline forms of 1-benzyl-N-(4-carbam... |
|
2021
|
Invention
|
Plasma kallikrein inhibitors for the treatment of ards and related conditions. Provided herein ar... |
|
2020
|
Invention
|
Processes for preparing plasma kallikrein inhibitors. A process for preparing and purifying a com... |
|
2019
|
Invention
|
Coiled tube emulsification methods.
Embodiments of the present technology may include a method o... |
|
2018
|
Invention
|
Coiled tube emulsification systems and methods. Embodiments of the present technology may include... |
|
|
Invention
|
Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates. E... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabet... |
|
|
Invention
|
Oral delivery of physiologically active substances. Embodiments may include a composition for ora... |
|
|
Invention
|
Oral delivery of physiologically active substances.
Embodiments may include a composition for or... |
|
2017
|
P/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and orphan indications Pharma... |
|
|
Invention
|
Coiled tube emulsification systems. Embodiments of the present technology may include a system fo... |
|
2016
|
Invention
|
Solvent extraction from biodegradable microparticles. Embodiments may also include a system for r... |
|
|
Invention
|
Amine pegylation methods for the preparation of site-specific protein conjugates. Examples includ... |
|
2015
|
Invention
|
Solvent extraction from biodegradable microparticles. Embodiments may include a method for reduci... |
|
|
Invention
|
Proteins and protein conjugates with increased hydrophobicity.
Examples may include a method of ... |
|
|
Invention
|
Site-specific insulin-polymer conjugates. The invention is directed to a single-step method for r... |
|
2004
|
Invention
|
Materials and methods for preparing protein-polymer conjugates. The invention is directed to a si... |
